Clinical Research

Clinical Trials

Axial Biotherapeutics Inc: The effect of AB-4166 on GI tolerability and gut microbiome in a free-living subset of Parkinson’s patients

Listen to your gut! Contribute to the Science of PD and GI function. A safety and tolerability study of AB-4166: safety assessment in a subset of subjects with Parkinson’s Disease.

  • Diagnosed with mild-to-moderate Parkinson’s
  • Male or female between the ages of 30-85 years of age
  • Able to commit to the full safety study duration of ~32 weeks

Status: Recruiting

Learn more about the Axial Biotherapeutics Safety Study on GI Tolerability and Gut Microbiome, and if you are interested call (650) 770-0205 or email

Questions about making a donation? Please call (650) 770-0201.

Email News and Updates

Join our mailing list to receive the latest news and updates from our team.

Parkinson's Institute and Clinical Center
2500 Hospital Drive, Building 10, Suite 1 | Mountain View, CA 94040
(650) 770-0201 main | (650) 770-0204 fax (secure clinic fax)

Federal Tax ID # 94-3061594